Pacira biosciences, inc. (PCRX)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Total revenues

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaborative licensing and milestone revenue

-

-

0

0

-

-

0

0

-

387

719

2,050

3,276

3,426

3,426

2,426

1,426

1,426

2,356

2,356

2,322

2,218

1,174

1,060

981

972

2,545

5,786

12,143

18,390

17,803

15,671

10,354

5,074

4,610

4,077

0

0

0

Total revenues

-

-

393,717

372,480

-

337,277

321,240

305,127

291,954

286,630

280,454

281,474

280,180

276,371

272,789

266,647

256,155

248,997

377,345

367,180

355,197

333,543

169,439

140,650

110,626

85,551

62,437

47,664

42,867

39,084

32,868

28,338

19,630

15,689

15,987

15,086

0

0

0

Operating expenses:
Cost of goods sold

109,141

106,712

98,787

95,548

91,263

86,845

84,161

83,324

86,219

87,915

90,241

115,165

114,407

110,104

105,910

78,659

74,535

71,837

129,850

134,340

135,365

135,912

76,848

71,248

61,508

54,772

46,068

40,564

37,035

32,139

29,067

23,137

19,567

16,739

13,712

13,204

0

0

0

Research and development

73,554

72,119

66,640

61,282

55,694

55,688

51,541

48,419

55,036

57,290

64,332

62,311

52,817

45,678

41,762

37,901

32,188

28,662

34,240

32,772

34,339

33,576

19,681

21,218

20,859

21,560

19,968

17,533

14,548

9,937

8,825

9,658

12,372

14,873

18,457

18,693

0

0

0

Selling, general and administrative

198,257

200,782

191,205

185,256

180,379

177,265

171,797

168,262

163,565

161,494

156,989

152,659

156,776

152,613

155,493

154,489

145,572

139,043

208,152

201,059

191,144

182,305

95,815

82,918

72,161

62,508

55,699

51,757

48,090

46,306

40,141

33,735

27,788

20,159

14,655

10,921

0

0

0

Amortization of acquired intangible assets

7,700

5,700

3,800

1,800

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition-related charges, product discontinuation and other

30,180

25,230

-9,190

-2,831

412

1,564

8,112

9,111

4,778

4,868

-4,755

-4,495

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-

-

372,687

349,815

-

321,362

309,123

300,630

309,778

311,567

316,317

334,630

324,000

308,395

303,165

271,049

252,295

239,542

372,242

368,171

360,848

351,793

192,344

175,384

154,528

138,840

121,735

109,854

99,673

88,382

81,052

69,549

62,746

54,790

46,824

42,818

0

0

0

Income from operations

26,495

10,480

21,030

22,665

23,931

15,915

12,117

4,497

-17,824

-24,937

-35,863

-53,156

-43,820

-32,024

-30,376

-4,402

3,860

9,455

5,103

-991

-5,651

-18,250

-22,905

-34,734

-43,902

-53,289

-59,298

-62,190

-56,806

-49,298

-48,184

-41,211

-43,116

-39,101

-30,837

-27,732

0

0

0

Other (expense) income:
Interest income

6,809

7,376

7,713

7,563

7,279

6,497

5,765

5,247

4,938

4,078

3,207

2,485

1,585

1,323

1,097

922

775

678

885

848

732

619

289

217

228

259

264

289

285

275

361

320

289

255

151

143

0

0

0

Interest expense

23,836

23,628

23,385

23,087

22,606

21,949

21,301

20,786

20,615

18,047

14,801

11,275

7,782

7,061

7,086

7,390

7,597

7,725

14,119

14,251

14,390

14,501

8,151

8,006

7,841

7,253

5,668

4,232

2,812

1,807

2,177

2,631

2,813

4,780

5,144

5,121

0

0

0

Loss on early extinguishment of debt

-

-

-

-

-

-

-

-

-

-3,732

-3,732

-3,732

-3,721

0

0

-51

0

-

0

0

-

0

0

0

-

-3,398

-3,398

-4,460

0

-

0

0

-

-

-

-

-

-

-

Royalty interest obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

71

394

467

603

652

573

632

657

623

610

100

82

278

54

316

-256

-227

210

759

0

0

0

Other, net

-9,141

-4,976

-4,242

-911

-902

-888

-699

74

232

167

94

7

-120

-82

-90

-90

0

-165

-241

-276

-360

-277

-134

-99

-76

-47

-31

-71

-92

-111

-101

-80

-63

71

94

218

0

0

0

Total other expense, net

-26,168

-21,228

-19,914

-16,435

-16,229

-16,340

-16,235

-15,465

-15,456

-17,534

-15,232

-12,515

-10,038

-5,820

-6,080

-6,559

-6,874

-7,335

-13,920

-14,197

-14,621

-14,811

-8,569

-8,520

-8,346

-11,062

-9,443

-7,512

-7,161

-2,983

-3,033

-3,769

-2,331

-4,227

-5,109

-5,519

0

0

0

Income (loss) before income taxes

327

-10,748

1,116

6,230

7,702

-425

-4,118

-10,968

-33,280

-42,471

-51,095

-65,671

-53,858

-37,844

-36,456

-10,961

-3,014

2,120

-8,817

-15,188

-20,272

-33,061

-31,474

-43,254

-52,248

-64,351

-68,741

-69,702

-63,967

-52,281

0

0

0

-

-

-

-

-

-

Income tax expense

415

268

-1,009

-1,371

264

46

43

150

145

140

84

75

103

105

18

263

244

264

545

264

225

173

0

0

0

-442

-442

0

0

-

0

-

-

-

-

-

-

-

-

Net income (loss)

-86

-11,016

2,157

7,604

7,438

-471

-4,161

-11,118

-33,425

-42,611

-51,179

-65,746

-53,961

-37,949

-36,474

-11,224

-3,258

1,856

-9,362

-15,452

-20,497

-33,234

-31,474

-43,254

-52,248

-63,909

-68,299

-69,260

-63,525

-52,281

-51,217

-44,980

-45,447

-43,328

-35,946

-33,251

0

0

0

Net income (loss) per share:
Basic and diluted net income (loss) per common share (in USD per share)

0.19

-

-0.15

-

-0.07

-

-0.02

-

-0.26

0.13

-0.19

-0.49

-0.52

-0.12

-0.59

-0.21

-0.10

-

-

0.00

0.03

-

-

-0.14

-0.34

-

-0.44

-0.42

-0.71

-0.49

-0.49

-0.27

-0.47

-0.60

-0.55

-0.51

-0.98

-13.77

-11.86

Basic net income (loss) per common share (in USD per share)

-

-

-

0.07

-

-

-

0.06

-

-

-

-

-

-

-

-

-

-

0.08

-

-

-0.39

-0.08

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted net income (loss per common share (in USD per share)

-

-

-

0.06

-

-

-

0.06

-

-

-

-

-

-

-

-

-

-

0.08

-

-

-0.39

-0.08

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average common shares outstanding:
Basic and diluted (in shares)

42,032

41,783

41,645

41,384

41,240

41,146

40,995

40,796

40,707

40,603

40,463

40,160

37,998

37,431

37,312

37,181

37,020

36,781

36,663

36,481

36,235

35,299

35,943

35,463

33,711

33,575

33,360

33,083

32,709

32,570

32,436

30,953

25,367

21,271

17,230

17,233

10,014

573

-

Diluted (in shares)

42,785

-

-

42,345

41,240

-

-

41,694

-

-

-

40,160

-

-

-

-

-

40,937

41,043

41,445

41,779

35,299

35,943

35,463

33,711

-

-

-

-

-

-

-

-

-

-

-

10,014

573

-

Basic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

574

Product
Total revenues

432,765

418,926

391,795

370,153

349,046

332,427

316,539

300,782

290,204

284,342

277,280

276,448

273,996

270,073

266,497

261,528

251,903

244,487

369,824

359,594

347,566

326,222

165,131

136,619

106,863

81,956

57,735

39,877

28,580

18,191

11,068

8,200

4,688

6,895

8,548

8,326

0

0

0

Royalty
Total revenues

2,632

2,100

1,922

2,327

1,937

1,850

1,676

1,294

1,569

1,901

2,455

2,976

2,908

2,872

2,866

2,693

2,826

3,084

5,165

5,230

5,309

5,103

3,134

2,971

2,782

2,623

2,157

2,001

2,144

2,503

3,005

3,437

0

-

0

0

-

0

0